Cargando…
Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department
Emergency departments (EDs) can serve as surveillance sites for infectious diseases. The objective of this study was to determine the burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to monitor the prevalence of vaccination against coronavirus disease 2019 (COVID-...
Autores principales: | , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925900/ https://www.ncbi.nlm.nih.gov/pubmed/35044204 http://dx.doi.org/10.1128/jcm.02390-21 |
_version_ | 1784670123561320448 |
---|---|
author | Beck, Evan J. Hsieh, Yu-Hsiang Fernandez, Reinaldo E. Dashler, Gaby Egbert, Emily R. Truelove, Shawn A. Garliss, Caroline Wang, Richard Bloch, Evan M. Shrestha, Ruchee Blankson, Joel Cox, Andrea L. Manabe, Yukari C. Kickler, Thomas Rothman, Richard E. Redd, Andrew D. Tobian, Aaron A. R. Milstone, Aaron M. Quinn, Thomas C. Laeyendecker, Oliver |
author_facet | Beck, Evan J. Hsieh, Yu-Hsiang Fernandez, Reinaldo E. Dashler, Gaby Egbert, Emily R. Truelove, Shawn A. Garliss, Caroline Wang, Richard Bloch, Evan M. Shrestha, Ruchee Blankson, Joel Cox, Andrea L. Manabe, Yukari C. Kickler, Thomas Rothman, Richard E. Redd, Andrew D. Tobian, Aaron A. R. Milstone, Aaron M. Quinn, Thomas C. Laeyendecker, Oliver |
author_sort | Beck, Evan J. |
collection | PubMed |
description | Emergency departments (EDs) can serve as surveillance sites for infectious diseases. The objective of this study was to determine the burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to monitor the prevalence of vaccination against coronavirus disease 2019 (COVID-19) among patients attending an urban ED in Baltimore City. Using 1,914 samples of known exposure status, we developed an algorithm to differentiate previously infected, vaccinated, and unexposed individuals using a combination of antibody assays. We applied this testing algorithm to 4,360 samples from ED patients obtained in the spring of 2020 and 2021. Using multinomial logistic regression, we determined factors associated with infection and vaccination. For the algorithm, sensitivity and specificity for identifying vaccinated individuals were 100% and 99%, respectively, and 84% and 100% for previously infected individuals. Among the ED subjects, seroprevalence to SARS-CoV-2 increased from 2% to 24% between April 2020 and March 2021. Vaccination prevalence rose to 11% by mid-March 2021. Marked differences in burden of disease and vaccination coverage were seen by sex, race, and ethnicity. Hispanic patients, though accounting for 7% of the study population, had the highest relative burden of disease (17% of total infections) but with similar vaccination rates. Women and white individuals were more likely to be vaccinated than men or Black individuals. Individuals previously infected with SARS-CoV-2 can often be differentiated from vaccinated individuals using a serologic testing algorithm. The utility of this algorithm can aid in monitoring SARS-CoV-2 exposure and vaccination uptake frequencies and can potentially reflect gender, race, and ethnic health disparities. |
format | Online Article Text |
id | pubmed-8925900 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society for Microbiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-89259002022-03-17 Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department Beck, Evan J. Hsieh, Yu-Hsiang Fernandez, Reinaldo E. Dashler, Gaby Egbert, Emily R. Truelove, Shawn A. Garliss, Caroline Wang, Richard Bloch, Evan M. Shrestha, Ruchee Blankson, Joel Cox, Andrea L. Manabe, Yukari C. Kickler, Thomas Rothman, Richard E. Redd, Andrew D. Tobian, Aaron A. R. Milstone, Aaron M. Quinn, Thomas C. Laeyendecker, Oliver J Clin Microbiol Epidemiology Emergency departments (EDs) can serve as surveillance sites for infectious diseases. The objective of this study was to determine the burden of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to monitor the prevalence of vaccination against coronavirus disease 2019 (COVID-19) among patients attending an urban ED in Baltimore City. Using 1,914 samples of known exposure status, we developed an algorithm to differentiate previously infected, vaccinated, and unexposed individuals using a combination of antibody assays. We applied this testing algorithm to 4,360 samples from ED patients obtained in the spring of 2020 and 2021. Using multinomial logistic regression, we determined factors associated with infection and vaccination. For the algorithm, sensitivity and specificity for identifying vaccinated individuals were 100% and 99%, respectively, and 84% and 100% for previously infected individuals. Among the ED subjects, seroprevalence to SARS-CoV-2 increased from 2% to 24% between April 2020 and March 2021. Vaccination prevalence rose to 11% by mid-March 2021. Marked differences in burden of disease and vaccination coverage were seen by sex, race, and ethnicity. Hispanic patients, though accounting for 7% of the study population, had the highest relative burden of disease (17% of total infections) but with similar vaccination rates. Women and white individuals were more likely to be vaccinated than men or Black individuals. Individuals previously infected with SARS-CoV-2 can often be differentiated from vaccinated individuals using a serologic testing algorithm. The utility of this algorithm can aid in monitoring SARS-CoV-2 exposure and vaccination uptake frequencies and can potentially reflect gender, race, and ethnic health disparities. American Society for Microbiology 2022-03-16 /pmc/articles/PMC8925900/ /pubmed/35044204 http://dx.doi.org/10.1128/jcm.02390-21 Text en https://doi.org/10.1128/AuthorWarrantyLicense.v1This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply. https://doi.org/10.1128/ASMCopyrightv2This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Epidemiology Beck, Evan J. Hsieh, Yu-Hsiang Fernandez, Reinaldo E. Dashler, Gaby Egbert, Emily R. Truelove, Shawn A. Garliss, Caroline Wang, Richard Bloch, Evan M. Shrestha, Ruchee Blankson, Joel Cox, Andrea L. Manabe, Yukari C. Kickler, Thomas Rothman, Richard E. Redd, Andrew D. Tobian, Aaron A. R. Milstone, Aaron M. Quinn, Thomas C. Laeyendecker, Oliver Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department |
title | Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department |
title_full | Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department |
title_fullStr | Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department |
title_full_unstemmed | Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department |
title_short | Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department |
title_sort | differentiation of individuals previously infected with and vaccinated for sars-cov-2 in an inner-city emergency department |
topic | Epidemiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925900/ https://www.ncbi.nlm.nih.gov/pubmed/35044204 http://dx.doi.org/10.1128/jcm.02390-21 |
work_keys_str_mv | AT beckevanj differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT hsiehyuhsiang differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT fernandezreinaldoe differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT dashlergaby differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT egbertemilyr differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT trueloveshawna differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT garlisscaroline differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT wangrichard differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT blochevanm differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT shrestharuchee differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT blanksonjoel differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT coxandreal differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT manabeyukaric differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT kicklerthomas differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT rothmanricharde differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT reddandrewd differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT tobianaaronar differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT milstoneaaronm differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT quinnthomasc differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment AT laeyendeckeroliver differentiationofindividualspreviouslyinfectedwithandvaccinatedforsarscov2inaninnercityemergencydepartment |